logo
Select company
Select metric
$ 5.49MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
26
Sector
46
Industry
36
History
25
$ 0.43Close
$ 0.36 - $ 4 52-Week Range
Ticker Information

Ticker

ADVB

Company Name

ADVANCED BIOMED INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

ADVANCED BIOMED INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ADVB - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 5.49M
12/31/2024$ -85.4K
6/30/2024$ -85.4K
6/30/2023$ 458.14K
6/30/2022$ 6.1M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ADVANCED BIOMED INC's latest trailing twelve months (TTM) CF - Equity stands at $ 6.1M.
  • Over the past 5 years, ADVANCED BIOMED INC's average CF - Equity has been $ 2.38M.
  • The median CF - Equity for ADVANCED BIOMED INC during this period was $ 458.14K
  • ADVANCED BIOMED INC reached its highest CF - Equity over the past 5 years at $ 6.1M.
  • The lowest CF - Equity recorded by ADVANCED BIOMED INC in the same timeframe $ -85.4K

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

ADVB - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -85.4K

Minimum

Jun 30, 2024

$ 6.1M

Maximum

Jun 30, 2022

$ 2.38M

Average

$ 458.14K

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 139.46K with a standard deviation of $ 17.67M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 139.46K
median$ 0
std$ 17.67M